Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context

Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context

Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment vis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rodrigues, Bárbara Emilly Matos, Branco, André Barbosa Castelo, Mendes, Igor Barbosa, Koch, Camila Ribeiro, Amaral, Bruno Andrade, Lindemberg Assunção Costa
Format: Dataset
Sprache:eng
Schlagworte:
FOS: Clinical medicine
Ophthalmology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Rodrigues, Bárbara Emilly Matos
Branco, André Barbosa Castelo
Mendes, Igor Barbosa
Koch, Camila Ribeiro
Amaral, Bruno Andrade
Lindemberg Assunção Costa
description Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.
doi_str_mv 10.6084/m9.figshare.7941695
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_7941695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_7941695</sourcerecordid><originalsourceid>FETCH-LOGICAL-d895-a6d94a433db49ba3270bf59916ae77d15bc8e3cfd2cc7d7f101447d690c334153</originalsourceid><addsrcrecordid>eNo1kE1OwzAUhLNhgQonYPMukGDXTlwvUcWfVAkJdR-92M-tpTiJbKdQrsClaaGsZjHzzeIrijvOqoat5H3QlfO7tMdIldKSN7q-Lr7fKccxTWSyPxCkPNsj5BEwJUoJ8p7AhwlNhtFBxMF3_msO2AGr6rADP_xODj7N2AOa2efjeTlh9jTkBB8-7yGcih4jWJ8IT79nDCHSCem9IzDjkOkz3xRXDvtEt5dcFNunx-36pdy8Pb-uHzalXem6xMZqiVII20ndoVgq1rlaa94gKWV53ZkVCePs0hhlleOMS6lso5kRQvJaLArxd2sxo_GZ2in6gPHYctaeTbVBt_-m2osp8QN4XWe-</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context</title><source>DataCite</source><creator>Rodrigues, Bárbara Emilly Matos ; Branco, André Barbosa Castelo ; Mendes, Igor Barbosa ; Koch, Camila Ribeiro ; Amaral, Bruno Andrade ; Lindemberg Assunção Costa</creator><creatorcontrib>Rodrigues, Bárbara Emilly Matos ; Branco, André Barbosa Castelo ; Mendes, Igor Barbosa ; Koch, Camila Ribeiro ; Amaral, Bruno Andrade ; Lindemberg Assunção Costa</creatorcontrib><description>Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.</description><identifier>DOI: 10.6084/m9.figshare.7941695</identifier><language>eng</language><publisher>SciELO journals</publisher><subject>FOS: Clinical medicine ; Ophthalmology</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>778,1890</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.7941695$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Rodrigues, Bárbara Emilly Matos</creatorcontrib><creatorcontrib>Branco, André Barbosa Castelo</creatorcontrib><creatorcontrib>Mendes, Igor Barbosa</creatorcontrib><creatorcontrib>Koch, Camila Ribeiro</creatorcontrib><creatorcontrib>Amaral, Bruno Andrade</creatorcontrib><creatorcontrib>Lindemberg Assunção Costa</creatorcontrib><title>Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context</title><description>Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.</description><subject>FOS: Clinical medicine</subject><subject>Ophthalmology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2019</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kE1OwzAUhLNhgQonYPMukGDXTlwvUcWfVAkJdR-92M-tpTiJbKdQrsClaaGsZjHzzeIrijvOqoat5H3QlfO7tMdIldKSN7q-Lr7fKccxTWSyPxCkPNsj5BEwJUoJ8p7AhwlNhtFBxMF3_msO2AGr6rADP_xODj7N2AOa2efjeTlh9jTkBB8-7yGcih4jWJ8IT79nDCHSCem9IzDjkOkz3xRXDvtEt5dcFNunx-36pdy8Pb-uHzalXem6xMZqiVII20ndoVgq1rlaa94gKWV53ZkVCePs0hhlleOMS6lso5kRQvJaLArxd2sxo_GZ2in6gPHYctaeTbVBt_-m2osp8QN4XWe-</recordid><startdate>20190403</startdate><enddate>20190403</enddate><creator>Rodrigues, Bárbara Emilly Matos</creator><creator>Branco, André Barbosa Castelo</creator><creator>Mendes, Igor Barbosa</creator><creator>Koch, Camila Ribeiro</creator><creator>Amaral, Bruno Andrade</creator><creator>Lindemberg Assunção Costa</creator><general>SciELO journals</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20190403</creationdate><title>Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context</title><author>Rodrigues, Bárbara Emilly Matos ; Branco, André Barbosa Castelo ; Mendes, Igor Barbosa ; Koch, Camila Ribeiro ; Amaral, Bruno Andrade ; Lindemberg Assunção Costa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d895-a6d94a433db49ba3270bf59916ae77d15bc8e3cfd2cc7d7f101447d690c334153</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2019</creationdate><topic>FOS: Clinical medicine</topic><topic>Ophthalmology</topic><toplevel>online_resources</toplevel><creatorcontrib>Rodrigues, Bárbara Emilly Matos</creatorcontrib><creatorcontrib>Branco, André Barbosa Castelo</creatorcontrib><creatorcontrib>Mendes, Igor Barbosa</creatorcontrib><creatorcontrib>Koch, Camila Ribeiro</creatorcontrib><creatorcontrib>Amaral, Bruno Andrade</creatorcontrib><creatorcontrib>Lindemberg Assunção Costa</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Rodrigues, Bárbara Emilly Matos</au><au>Branco, André Barbosa Castelo</au><au>Mendes, Igor Barbosa</au><au>Koch, Camila Ribeiro</au><au>Amaral, Bruno Andrade</au><au>Lindemberg Assunção Costa</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context</title><date>2019-04-03</date><risdate>2019</risdate><abstract>Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.</abstract><pub>SciELO journals</pub><doi>10.6084/m9.figshare.7941695</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.7941695
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_7941695
source DataCite
subjects FOS: Clinical medicine
Ophthalmology
title Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Rodrigues,%20B%C3%A1rbara%20Emilly%20Matos&rft.date=2019-04-03&rft_id=info:doi/10.6084/m9.figshare.7941695&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_7941695%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true